Literature DB >> 20446239

Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia.

S Verma1, L Green-Golan, C VanRyzin, B Drinkard, S P Mehta, M Weise, G Eisenhofer, D P Merke.   

Abstract

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is classified into three types based on disease severity: classic salt-wasting, classic simple virilizing, and nonclassic. Adrenomedullary dysplasia and epinephrine deficiency have been described in classic CAH, resulting in glucose dysregulation. Our objective was to investigate adrenomedullary function in nonclassic CAH and to evaluate adrenomedullary function according to disease severity. Adrenomedullary function was evaluated in response to a standardized cycle ergonometer test in 23 CAH patients (14 females, age 9-38 years; 6 salt-wasting, 7 simple virilizing, 5 nonclassic receiving glucocorticoid treatment, 5 nonclassic not receiving glucocorticoid), and 14 controls (7 females, age 12-38 years). Epinephrine, glucose, and cortisol were measured at baseline and peak exercise. CAH patients and controls were similar in age and anthropometric measures. Patients with nonclassic CAH who were not receiving glucocorticoid and controls experienced the expected stress-induced rise in epinephrine, glucose, and cortisol. Compared to controls, patients with all types of CAH receiving glucocorticoid had impaired exercise-induced changes in epinephrine (salt-wasting: p=0.01;simple virilizing: p=0.01; nonclassic: p=0.03), and cortisol (salt-wasting: p=0.004; simple virilizing: p=0.006; nonclassic: p=0.03). Salt-wasting patients displayed the most significant impairment, including impairment in glucose response relative to controls (p=0.03). Hydrocortisone dose was negatively correlated with epinephrine response (r=-0.58; p=0.007) and glucose response (r=-0.60; p=0.002). The present study demonstrates that untreated patients with nonclassic CAH have normal adrenomedullary function. The degree of epinephrine deficiency in patients with CAH is associated with the severity of adrenocortical dysfunction, as well as glucocorticoid therapy. (c) Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446239      PMCID: PMC7473418          DOI: 10.1055/s-0030-1253385

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  33 in total

1.  Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  F G Riepe; N Krone; S N Krüger; F C G J Sweep; J W M Lenders; J Dötsch; H Mönig; W G Sippell; C-J Partsch
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-03       Impact factor: 2.949

2.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency.

Authors:  N Zuckerman-Levin; D Tiosano; G Eisenhofer; S Bornstein; Z Hochberg
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

4.  Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.

Authors:  D P Merke; G P Chrousos; G Eisenhofer; M Weise; M F Keil; A D Rogol; J J Van Wyk; S R Bornstein
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

5.  [Significance of the 2-deoxy-d-glucose-test on the differentiation of hypoglycemia in childhood (author's transl)].

Authors:  K Kruse; H Bartels
Journal:  Klin Padiatr       Date:  1975-07       Impact factor: 1.349

6.  Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

Authors:  Evangelia Charmandari; Graeme Eisenhofer; Sarah L Mehlinger; Ann Carlson; Robert Wesley; Margaret F Keil; George P Chrousos; Maria I New; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

7.  Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise.

Authors:  Martina Weise; Sarah L Mehlinger; Bart Drinkard; Erin Rawson; Evangelia Charmandari; Mayumi Hiroi; Graeme Eisenhofer; Jack A Yanovski; George P Chrousos; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

8.  Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.

Authors:  Maud Bidet; Christine Bellanné-Chantelot; Marie-Béatrice Galand-Portier; Véronique Tardy; Line Billaud; Kathleen Laborde; Christiane Coussieu; Yves Morel; Christelle Vaury; Jean-Louis Golmard; Aurélie Claustre; Etienne Mornet; Zeina Chakhtoura; Irene Mowszowicz; Anne Bachelot; Philippe Touraine; Frédérique Kuttenn
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

9.  Frequency of hypoglycemia in children with adrenal insufficiency.

Authors:  E Artavia-Loria; J L Chaussain; P F Bougnères; J C Job
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986

10.  Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise.

Authors:  Martina Weise; Bart Drinkard; Sarah L Mehlinger; Stuart M Holzer; Graeme Eisenhofer; Evangelia Charmandari; George P Chrousos; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  5 in total

1.  Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families.

Authors:  Radha Nandagopal; Ninet Sinaii; Nilo A Avila; Carol Van Ryzin; Wuyan Chen; Gabriela P Finkielstain; Sneha P Mehta; Nazli B McDonnell; Deborah P Merke
Journal:  Eur J Endocrinol       Date:  2011-03-28       Impact factor: 6.664

2.  Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Diala El-Maouche; Suzanne Collier; Mala Prasad; James C Reynolds; Deborah P Merke
Journal:  Clin Endocrinol (Oxf)       Date:  2014-06-28       Impact factor: 3.478

3.  Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.

Authors:  Gabriela P Finkielstain; Mimi S Kim; Ninet Sinaii; Miki Nishitani; Carol Van Ryzin; Suvimol C Hill; James C Reynolds; Reem M Hanna; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2012-09-18       Impact factor: 5.958

Review 4.  Adrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research.

Authors:  Jessica H Lee; David J Torpy
Journal:  Rev Endocr Metab Disord       Date:  2022-07-11       Impact factor: 9.306

Review 5.  Non-Classical Congenital Adrenal Hyperplasia in Childhood.

Authors:  Selim Kurtoğlu; Nihal Hatipoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.